ClinicalTrials.gg

Program

IMG-007

A development code.

Its studies are mostly in Dermatitis, Atopic · Alopecia Areata, led by Inmagene.

Furthest: phase 2, since Jul 25, 20235 company-led studies, 2 open or runningNext primary completion: Dec 2027 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Inmagene52 open or runningphase 2since Jul 25, 2023Jul 25, 2023Dec 2027phase 2 · NCT07037901

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 25, 2023First study: phase 2 study in Dermatitis, AtopicFirst studyNCT05984784 · 13 enrolled · United States, Canada
  2. Sep 21, 2023Phase 2 study in Alopecia AreataNCT06060977 · 29 enrolled · United States, Canada
  3. Mar 3, 2024Phase 1 study in Healthy VolunteersNCT06304740 · 16 enrolled · Australia
  4. Jun 17, 2025Phase 2 study in Dermatitis, AtopicNCT07037901 · 405 planned · United States, Australia, Canada and more
  5. Jun 11, 2026Phase 2 study in Dermatitis, AtopicNCT07734415 · 400 planned · United States, Canada

Ahead

  1. Dec 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07037901
  2. Mar 2028Primary completion: phase 2 study in Dermatitis, AtopicNCT07734415

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07734415Dermatitis, Atopic · United States, Canada2By invitationMar 2028400
NCT07037901Dermatitis, Atopic · United States, Australia, Canada and more2RecruitingDec 2027405
NCT06304740Healthy Volunteers · Australia1TerminatedAug 28, 202416
NCT06060977Alopecia Areata · United States, Canada2CompletedJan 14, 202529
NCT05984784Dermatitis, Atopic · United States, Canada2TerminatedApr 26, 202413

How it is read

Names in the registry

  • “IMG-007”, 5 entries

Codes read as this program: IMG007.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.